Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Alkermes plc (ALKS) vs AMNEAL PHARMACEUTICALS, INC. (AMRX)

Alkermes plc and AMNEAL PHARMACEUTICALS, INC. are both Drug Manufacturers Specialty & Generic companies. Alkermes plc and AMNEAL PHARMACEUTICALS, INC. are of similar size ($6.8B and $6.3B). AMNEAL PHARMACEUTICALS, INC. trades at the lower P/E: 39.5× against 101×. Alkermes plc grew revenue faster over the last twelve months: 10.8% against 9.28%. AMNEAL PHARMACEUTICALS, INC. has the higher net margin (5.05% vs 3.97%) and the higher return on invested capital (11.1% vs 2.76%). Across the 21 metrics below, AMNEAL PHARMACEUTICALS, INC. leads on 11 and Alkermes plc on 10.

Valuation

Metric ALKS AMRX Drug Manufacturers Specialty & Generic median
P/E 101.36 39.54 20.14
P/S 4.09 2.02 2.25
P/B 3.77 191.09 1.90
Price to free cash flow 30.64 n/m 16.54
EV/EBITDA 34.45 13.30 12.29
EV/Sales 4.60 2.84 2.56
Earnings yield 0.99% 2.53% (2.99%)
Free cash flow yield 3.26% (0.18%) 0.00%

Profitability

Metric ALKS AMRX Drug Manufacturers Specialty & Generic median
Gross margin 84.56% 39.32% 53.94%
Operating margin 7.03% 14.56% 0.00%
Net margin 3.97% 5.05% 0.00%
Free cash flow margin 13.35% (0.37%) 0.00%
Return on equity 3.85% (395.84%) (0.40%)
Return on assets 1.99% 4.37% (3.32%)
Return on invested capital 2.76% 11.05% 0.00%

Growth

Metric ALKS AMRX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 10.79% 9.28% 10.01%
EPS growth (last fiscal year) (34.10%) 157.89% —
Revenue growth, 5-year CAGR 7.28% 8.66% 6.74%
Net income growth, 5-year CAGR 0.00% (4.57%) 0.00%

Health

Metric ALKS AMRX Drug Manufacturers Specialty & Generic median
Debt to equity 0.83 80.86 0.05
Current ratio 2.30 2.20 2.31
Net debt to EBITDA (4.69) 3.62 0.85

Dividend

Metric ALKS AMRX Drug Manufacturers Specialty & Generic median
Dividend yield — 0.27% 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ALKS AMRX Drug Manufacturers Specialty & Generic median
Market cap 6.78b 6.32b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack